AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 157 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $212,000 | -26.6% | 14,020 | +163.3% | 0.00% | +100.0% |
Q1 2018 | $289,000 | -4.6% | 5,324 | +5.1% | 0.00% | 0.0% |
Q4 2017 | $303,000 | -6.5% | 5,066 | -24.1% | 0.00% | 0.0% |
Q3 2017 | $324,000 | -74.9% | 6,672 | -80.5% | 0.00% | -75.0% |
Q4 2016 | $1,292,000 | +4.5% | 34,135 | +4.2% | 0.00% | 0.0% |
Q3 2016 | $1,236,000 | – | 32,751 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |